The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics—A Novel Way to Combat Antibiotic Resistance?
Open accessAbstract
Rapidly growing resistance of pathogenic bacteria to conventional antibiotics leads to inefficiency of traditional approaches of countering infections and determines the urgent need for a search of fundamentally new anti-infective drugs. Antimicrobial peptides (AMPs) of the innate immune system are promising candidates for a role of such novel antibiotics. However, some cytotoxicity of AMPs toward host cells limits their active implementation in medicine and forces attempts to design numerous structural analogs of the peptides with optimized properties. An alternative route for the successful AMPs introduction may be their usage in combination with conventional antibiotics. Synergistic antibacterial effects have been reported for a number of such combinations, however, the molecular mechanisms of the synergy remain poorly understood and little is known whether AMPs cytotoxicy for the host cells increases upon their application with antibiotics. Our study is directed to examination of a combined action of natural AMPs with different structure and mode of action (porcine protegrin 1, caprine bactenecin ChBac3.4, human alpha- and beta-defensins (HNP-1, HNP-4, hBD-2, hBD-3), human cathelicidin LL-37), and egg white lysozyme with varied antibiotic agents (gentamicin, ofloxacin, oxacillin, rifampicin, polymyxin B, silver nanoparticles) toward selected bacteria, including drug-sensitive and drug-resistant strains, as well as toward some mammalian cells (human erythrocytes, PBMC, neutrophils, murine peritoneal macrophages and Ehrlich ascites carcinoma cells). Using "checkerboard titrations" for fractional inhibitory concentration indexes evaluation, it was found that synergy in antibacterial action mainly occurs between highly membrane-active AMPs (e.g., protegrin 1, hBD-3) and antibiotics with intracellular targets (e.g., gentamicin, rifampcin), suggesting bioavailability increase as the main model of such interaction. In some combinations modulation of dynamics of AMP-bacterial membrane interaction in presence of the antibiotic was also shown. Cytotoxic effects of the same combinations toward normal eukaryotic cells were rarely synergistic. The obtained data approve that combined application of antimicrobial peptides with antibiotics or other antimicrobials is a promising strategy for further development of new approach for combating antibiotic-resistant bacteria by usage of AMP-based therapeutics. Revealing the conventional antibiotics that increase the activity of human endogenous AMPs against particular pathogens is also important for cure strategies elaboration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed · Cited by 4,516
How to measure and predict the molar absorption coefficient of a protein
Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., & Gray, T. (1995) · Protein Science · doi:10.1002/pro.5560041120 · Cited by 3,907
Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles
Dakal, T. C., Kumar, A., Majumdar, R. S., & Yadav, V. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01831 · Cited by 2,135
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Rai, M. K., Deshmukh, S. D., Ingle, A. P., & Gade, A. K. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05253.x · Cited by 1,524
Carbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
Lai, Y., & Gallo, R. L. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.003 · Cited by 1,276
On a remarkable bacteriolytic element found in tissues and secretions
Fleming, A. (1922) · Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character · doi:10.1098/rspb.1922.0023 · Cited by 1,148
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Describing the Mechanism of Antimicrobial Peptide Action with the Interfacial Activity Model
Wimley, W. C. (2010) · ACS Chemical Biology · doi:10.1021/cb1001558 · Cited by 1,001
Mechanisms of drug combinations: interaction and network perspectives
Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2683 · Cited by 969
Epithelial antimicrobial defence of the skin and intestine
Gallo, R. L., & Hooper, L. V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3228 · Cited by 957
History of the Medical Use of Silver
Alexander, J. W. (2009) · Surgical Infections · doi:10.1089/sur.2008.9941 · Cited by 851
From antimicrobial to anticancer peptides. A review
Gaspar, D., Veiga, A. S., & Castanho, M. A. R. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00294 · Cited by 749
Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds
Lara, H. H., Garza-Treviño, E. N., Ixtepan-Turrent, L., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-30 · Cited by 741
Control of cell selectivity of antimicrobial peptides
Matsuzaki, K. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.013 · Cited by 713
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
Update on the antibiotic resistance crisis
Rossolini, G. M., Arena, F., Pecile, P., & Pollini, S. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.09.006 · Cited by 695
Role of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
Antimicrobial peptides: The ancient arm of the human immune system
Wiesner, J., & Vilcinskas, A. (2010) · Virulence · doi:10.4161/viru.1.5.12983 · Cited by 684
Mechanism of bactericidal action of aminoglycosides
Davis, B. D. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.3.341-350.1987 · Cited by 620
Analysis of combined drug effects: a new look at a very old problem
Chou, T.-C., & Talalay, P. (1983) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(83)90490-x · Cited by 619
Intracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Recommendations for euthanasia of experimental animals: Part 1
Close, B., Banister, K., Baumans, V., Bernoth, E.-M., Bromage, N., Bunyan, J., Erhardt, W., Flecknell, P., Gregory, N., Hackbarth, H., et al. (1996) · Laboratory Animals · doi:10.1258/002367796780739871 · Cited by 599
Bacterial uptake of aminoglycoside antibiotics
Taber, H. W., Mueller, J. P., Miller, P. F., & Arrow, A. S. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.4.439-457.1987 · Cited by 598
Role of membranes in the activities of antimicrobial cationic peptides
Hancock, R. (2002) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00480-3 · Cited by 574
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Vandamme, D., Landuyt, B., Luyten, W., & Schoofs, L. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.009 · Cited by 567
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., & Terán, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 549
Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski, L. D. S., Silva-Pereira, I., & Kyaw, C. M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00353 · Cited by 546
Kokryakov, V. N., Harwig, S. S. L., Panyutich, E. A., Shevchenko, A. A., Aleshina, G. M., Shamova, O. V., Korneva, H. A., & Lehrer, R. I. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80175-t · Cited by 518
Self-citationStensberg, M. C., Wei, Q., McLamore, E. S., Porterfield, D. M., Wei, A., & Sepúlveda, M. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.78 · Cited by 491
Host defense peptides: front-line immunomodulators
Mansour, S. C., Pena, O. M., & Hancock, R. E. W. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.07.004 · Cited by 488
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 481
Antimicrobial Properties of Lysozyme in Relation to Foodborne Vegetative Bacteria
Masschalck, B., & Michiels, C. W. (2003) · Critical Reviews in Microbiology · doi:10.1080/713610448 · Cited by 442
Beta‐lactam antibiotics: from antibiosis to resistance and bacteriology
KONG, K., SCHNEPER, L., & MATHEE, K. (2010) · APMIS · doi:10.1111/j.1600-0463.2009.02563.x · Cited by 433
α‐Defensins in human innate immunity
Lehrer, R. I., & Lu, W. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01082.x · Cited by 429
Ouhara, K., Komatsuzawa, H., Yamada, S., Shiba, H., Fujiwara, T., Ohara, M., Sayama, K., Hashimoto, K., Kurihara, H., & Sugai, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki103 · Cited by 428
Rifampin: Mechanisms of Action and Resistance
Wehrli, W. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s407 · Cited by 397
Antimicrobial hydrogels: promising materials for medical application
Yang, K., Han, Q., Chen, B., Zheng, Y., Zhang, K., Li, Q., & Wang, J. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s154748 · Cited by 397
Innate immune responses to infection
Tosi, M. F. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.036 · Cited by 391
Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity
Steinberg, D. A., Hurst, M. A., Fujii, C. A., Kung, A. H., Ho, J. F., Cheng, F. C., Loury, D. J., & Fiddes, J. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1738 · Cited by 384
Orhan, G., Bayram, A., Zer, Y., & Balci, I. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.140-143.2005 · Cited by 357
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350
Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function
Ibrahim, H. R., Matsuzaki, T., & Aoki, T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02872-1 · Cited by 350
Salivary Defense Proteins: Their Network and Role in Innate and Acquired Oral Immunity
Fábián, T. K., Hermann, P., Beck, A., Fejérdy, P., & Fábián, G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13044295 · Cited by 348
In vitro and In vivo Wound Healing-Promoting Activities of Human Cathelicidin LL-37
Carretero, M., Escámez, M. J., García, M., Duarte, B., Holguín, A., Retamosa, L., Jorcano, J. L., Río, M. D., & Larcher, F. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701043 · Cited by 345
Synergy, additivism and antagonism in immunosuppression. A critical review.
Berenbaum, M. C. (1977) · PubMed · Cited by 336
Silver nanoparticle protein corona and toxicity: a mini-review
Durán, N., Silveira, C. P., Durán, M., & Martinez, D. S. T. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0114-4 · Cited by 333
Takahashi, D., Shukla, S. K., Prakash, O., & Zhang, G. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.023 · Cited by 331
de la Fuente-Núñez, C., Reffuveille, F., Mansour, S. C., Reckseidler-Zenteno, S. L., Hernández, D., Brackman, G., Coenye, T., & Hancock, R. E. W. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.01.002 · Cited by 323
Systematic exploration of synergistic drug pairs
Cokol, M., Chua, H. N., Tasan, M., Mutlu, B., Weinstein, Z. B., Suzuki, Y., Nergiz, M. E., Costanzo, M., Baryshnikova, A., Giaever, G., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.71 · Cited by 315
The antibiotic resistance crisis: part 2: management strategies and new agents.
Ventola, C. L. (2015) · PubMed · Cited by 306
Cavassin, E. D., de Figueiredo, L. F. P., Otoch, J. P., Seckler, M. M., de Oliveira, R. A., Franco, F. F., Marangoni, V. S., Zucolotto, V., Levin, A. S. S., & Costa, S. F. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0120-6 · Cited by 300
Control of Biofilm Formation: Antibiotics and Beyond
Algburi, A., Comito, N., Kashtanov, D., Dicks, L. M. T., & Chikindas, M. L. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.02508-16 · Cited by 299
Natural roles of antimicrobial peptides in microbes, plants and animals
Maróti, G., Kereszt, A., Kondorosi, É., & Mergaert, P. (2011) · Research in Microbiology · doi:10.1016/j.resmic.2011.02.005 · Cited by 298
Antimicrobial Peptides: An Introduction
Haney, E. F., Mansour, S. C., & Hancock, R. E. W. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6737-7_1 · Cited by 296
Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
Chung, P. Y., & Khanum, R. (2017) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2016.12.005 · Cited by 296
Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity
Ramanathan, B., Davis, E. G., Ross, C. R., & Blecha, F. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01549-6 · Cited by 268
Synergistic Interactions between Mammalian Antimicrobial Defense Peptides
Yan, H., & Hancock, R. E. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1558-1560.2001 · Cited by 259
Human β-Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci
Sass, V., Schneider, T., Wilmes, M., Körner, C., Tossi, A., Novikova, N., Shamova, O., & Sahl, H.-G. (2010) · Infection and Immunity · doi:10.1128/iai.00688-09 · Cited by 254
Self-citationRole of the Escherichia coli SbmA in the antimicrobial activity of proline‐rich peptides
Mattiuzzo, M., Bandiera, A., Gennaro, R., Benincasa, M., Pacor, S., Antcheva, N., & Scocchi, M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05903.x · Cited by 248
Synergy assessed by checkerboard a critical analysis
Hsieh, M. H., Yu, C. M., Yu, V. L., & Chow, J. W. (1993) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(93)90087-n · Cited by 228
Silver nanoparticles as an alternative strategy against bacterial biofilms.
Markowska, K., Grudniak, A. M., & Wolska, K. I. (1970) · Acta Biochimica Polonica · doi:10.18388/abp.2013_2016 · Cited by 227
Ruden, S., Hilpert, K., Berditsch, M., Wadhwani, P., & Ulrich, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01106-08 · Cited by 225
The short proline-rich antibacterial peptide family
Otvos, Jr. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8493-8 · Cited by 224
Functional interaction of human neutrophil peptide‐1 with the cell wall precursor lipid II
de Leeuw, E., Li, C., Zeng, P., Li, C., Buin, M. D.-D., Lu, W.-Y., Breukink, E., & Lu, W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.004 · Cited by 222
Combination Effects of Antimicrobial Peptides
Yu, G., Baeder, D. Y., Regoes, R. R., & Rolff, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02434-15 · Cited by 220
Lehrer, R. I., Barton, A., & Ganz, T. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90414-0 · Cited by 211
Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation
Wilmes, M., Cammue, B. P. A., Sahl, H.-G., & Thevissen, K. (2011) · Natural Product Reports · doi:10.1039/c1np00022e · Cited by 207
Laible, N. J., & Germaine, G. R. (1985) · Infection and Immunity · doi:10.1128/iai.48.3.720-728.1985 · Cited by 206
Chen, X., Niyonsaba, F., Ushio, H., Okuda, D., Nagaoka, I., Ikeda, S., Okumura, K., & Ogawa, H. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.03.014 · Cited by 203
Antimicrobial peptides: therapeutic potentials
Kang, S.-J., Park, S. J., Mishig-Ochir, T., & Lee, B.-J. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.976613 · Cited by 203
Vaara, M., & Porro, M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1801 · Cited by 198
Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides
Scott, M. G., Yan, H., & Hancock, R. E. W. (1999) · Infection and Immunity · doi:10.1128/.67.4.2005-2009.1999 · Cited by 189
The mechanism of inhibition of protein synthesis by the proline-rich peptide oncocin
Roy, R. N., Lomakin, I. B., Gagnon, M. G., & Steitz, T. A. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3031 · Cited by 184
Synthesis and Solution Structure of the Antimicrobial Peptide Protegrin‐1
Aumelas, A., Mangoni, M., Roumestand, C., Chiche, L., Despaux, E., Grassy, G., Calas, B., & Chavanieu, A. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0575p.x · Cited by 181
Moerman, L., Bosteels, S., Noppe, W., Willems, J., Clynen, E., Schoofs, L., Thevissen, K., Tytgat, J., Van Eldere, J., van der Walt, J., et al. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03177.x · Cited by 178
Deslouches, B., Steckbeck, J. D., Craigo, J. K., Doi, Y., Mietzner, T. A., & Montelaro, R. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02218-12 · Cited by 173
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
Sakoulas, G., Okumura, C. Y. M., Thienphrapa, W., Olson, J., Nonejuie, P., Dam, Q., Dhand, A., Pogliano, J., Yeaman, M. R., Hensler, M. E., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1100-7 · Cited by 153
Novel Formulations for Antimicrobial Peptides
Carmona‐Ribeiro, A. M., & Carrasco, L. D. D. M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018040 · Cited by 153
Wu, X., Li, Z., Li, X., Tian, Y., Fan, Y., Yu, C., Zhou, B., Liu, Y., Xiang, R., & Yang, L. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s107195 · Cited by 150
Influence of Proline Residues on the Antibacterial and Synergistic Activities of α-Helical Peptides
Zhang, L., Benz, R., & Hancock, R. E. W. (1999) · Biochemistry · doi:10.1021/bi9904104 · Cited by 145
Machado, L. R., & Ottolini, B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00115 · Cited by 135
Structure–activity relationships in β‐defensin peptides
Taylor, K. J., Barran, P. E., & Dorin, J. R. (2007) · Biopolymers · doi:10.1002/bip.20900 · Cited by 133
Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK
Zahn, M., Berthold, N., Kieslich, B., Knappe, D., Hoffmann, R., & Sträter, N. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.041 · Cited by 126 · cited 1×
“, 2015) or interfering with the chaperonedependent protein folding (Otvos, 2002; Scocchi et al., 2009; Zahn et al., 2013), as described for other proline-rich peptides.”
BackgroundMohanty, S., Jena, P., Mehta, R. K., Pati, R., Banerjee, B., Patil, S. V., & Sonawane, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02475-12 · Cited by 125
Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens
LaRock, C. N., & Nizet, V. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.02.010 · Cited by 124
Giacometti, A., Cirioni, O., Barchiesi, F., Fortuna, M., & Scalise, G. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.5.641 · Cited by 105
Rajasekaran, G., Kim, E. Y., & Shin, S. Y. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.01.037 · Cited by 101
Oncolytic Activities of Host Defense Peptides
Al‐Benna, S., Shai, Y., Jacobsen, F., & Steinstraesser, L. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12118027 · Cited by 100
Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis
Mukae, H. (2002) · Thorax · doi:10.1136/thorax.57.7.623 · Cited by 95
Giacometti, A., Cirioni, O., Prete, M. S. D., Paggi, A. M., D’Errico, M. M., & Scalise, G. (2000) · Peptides · doi:10.1016/s0196-9781(00)00254-0 · Cited by 93
Insect antimicrobial peptides act synergistically to inhibit a trypanosome parasite
Marxer, M., Vollenweider, V., & Schmid‐Hempel, P. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0302 · Cited by 86
Zhang, Y., Lu, W., & Hong, M. (2010) · Biochemistry · doi:10.1021/bi101512j · Cited by 85
Navani, N. K., Lambadi, P. R., Sharma, T., Kumar, P., Vasnani, P., Thalluri, S. M., Bisht, N., & Pathania, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s72923 · Cited by 84
Feng, Q., Huang, Y., Chen, M. W., Li, G., & Chen, Y. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2219-3 · Cited by 81
Computational studies of protegrin antimicrobial peptides: A review
Bolintineanu, D., & Kaznessis, Y. N. (2010) · Peptides · doi:10.1016/j.peptides.2010.10.006 · Cited by 81
Giacometti, A., Cirioni, O., Barchiesi, F., & Scalise, G. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00175-9 · Cited by 79
Ghosh, S. K., Gerken, T. A., Schneider, K. M., Feng, Z., McCormick, T. S., & Weinberg, A. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.081430 · Cited by 72
Anantharaman, A., Rizvi, M. S., & Sahal, D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01231-09 · Cited by 68
Cirioni, O., Silvestri, C., Ghiselli, R., Orlando, F., Riva, A., Mocchegiani, F., Chiodi, L., Castelletti, S., Gabrielli, E., Saba, V., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn393 · Cited by 65
Soren, O., Brinch, K. S., Patel, D., Liu, Y., Liu, A., Coates, A. R. M., & Hu, Y. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01245-15 · Cited by 57
Organic carbon inventories in natural and restored Ecuadorian mangrove forests
DelVecchia, A. G., Bruno, J. F., Benninger, L. K., Alperin, M. J., Banerjee, O., & Morales, J. D. D. (2014) · PeerJ · doi:10.7717/peerj.388 · Cited by 57
He, J., Starr, C. G., & Wimley, W. C. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.09.010 · Cited by 55
Sánchez-Gómez, S., Japelj, B., Jerala, R., Moriyón, I., Alonso, M. F., Leiva, J., Blondelle, S. E., Andrä, J., Brandenburg, K., Lohner, K., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00904-10 · Cited by 55
Payne, J., Dubois, A. V., Ingram, R. J., Weldon, S., Taggart, C. C., Elborn, J. S., & Tunney, M. M. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.04.014 · Cited by 54
EFFECT OF POLYMYXIN ON THE LYSIS OF NEISSERIA CATARRHALIS BY LYSOZYME
Warren, G. H., Gray, J., & Yurchenco, J. A. (1957) · Journal of Bacteriology · doi:10.1128/jb.74.6.788-793.1957 · Cited by 53
Bessa, L. J., Eaton, P. J., Dematei, A., Plácido, A., Vale, N., Gomes, P. A. C., Delerue-Matos, C. M., Leite, J. R. S. A., & Gameiro, P. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0175 · Cited by 52
Davis, B. D. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.2.237 · Cited by 49
Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B.
Rosenthal, K. S., & Storm, D. R. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.1087 · Cited by 47
Pollini, S., Brunetti, J., Sennati, S., Rossolini, G. M., Bracci, L., Pini, A., & Falciani, C. (2017) · Journal of Peptide Science · doi:10.1002/psc.2978 · Cited by 47
Blanchette, K. A., & Wenke, J. C. (2018) · Journal of Bone and Joint Infection · doi:10.7150/jbji.23423 · Cited by 47
Knappe, D., Kabankov, N., Herth, N., & Hoffmann, R. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0083 · Cited by 23
ChBac3.4: A Novel Proline-Rich Antimicrobial Peptide from Goat Leukocytes
Валерьевна, Ш. О., Orlov, D. S., Stegemann, C., Czihal, P., Hoffmann, R., Brogden, K. A., Kolodkin, N. I., Sakuta, G. A., Tossi, A., Sahl, H., et al. (2009) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-009-9170-7 · Cited by 16
Self-citationEfficacy of Cryptdin-2 as an Adjunct to Antibiotics from Various Generations Against Salmonella
Singh, A. P., Prabha, V., & Rishi, P. (2014) · Indian Journal of Microbiology · doi:10.1007/s12088-014-0463-y · Cited by 11
Niu, M., Li, X., Gong, Q., Wang, C., Qin, C., Wang, W., & Chen, P. (2012) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-012-1181-4 · Cited by 8
Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients
Mattar, E. H., Almehdar, H. A., Aljaddawi, A. A., Zeid, I. M. A., & Redwan, E. M. M. M. (2016) · Journal of Immunology Research · doi:10.1155/2016/8373819 · Cited by 7
Turnidge, J. D. (2013) · Springer eBooks · doi:10.1007/978-0-387-75613-4_8 · Cited by 6
Cited by
Coronavirus infections and immune responses
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25685 · Cited by 1,946
The value of antimicrobial peptides in the age of resistance
Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., Giulianotti, M. A., Apidianakis, Y., Bradfute, S., Ferguson, A. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30327-3 · Cited by 1,150
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 567
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds
Erdem Büyükkiraz, M., & Kesmen, Z. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15314 · Cited by 454
Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic
Ferraboschi, P., Ciceri, S., & Grisenti, P. (2021) · Antibiotics · doi:10.3390/antibiotics10121534 · Cited by 448
Metadata
- Authors
- Zharkova, M. S., Orlov, D. S., Golubeva, O. Y., Chakchir, O. B., Eliseev, I. E., Grinchuk, T. M., & Shamova, O. V.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2019-04-30
- Volume
- 9
- Pages
- 128-128
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W2943071230
- Cited by
- 272
- References
- 127
- FWCI
- 22.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.